Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PPD has opened an office in Novosibirsk, Russia, building on the growth of its Phase II-IV clinical development services in Eastern Europe, to provide clinical monitoring services in key therapeutic areas.
Subscribe to our email newsletter
PPD, which already has offices in Moscow, Smolensk and St Petersburg, intends to strengthen its presence in Russia with this new office.
PPD is a contract research organisation (CRO), providing drug discovery, development and lifecycle management services to pharmaceutical, biotechnology, medical device, academic and government organisations.
PPD Europe, Middle East and Africa clinical development vice president Roger Newbery said that establishing a presence in Novosibirsk allows them to serve clients more effectively and keep pace with clinical trial growth in this region.